AAV9-TAZ gene replacement ameliorates cardiac TMT proteomic profiles in a mouse model of Barth syndrome

Authors

Silveli Suzuki-Hatano, University of Florida
Madhurima Saha, University of Florida
Meghan S. Soustek, University of Florida
Peter B. Kang, University of Florida
Barry J. Byrne, University of Florida
W. Todd Cade, Washington University School of Medicine in St. Louis
Christina A. Pacak, University of Florida

Journal

Molecular Therapy-Methods & Clinical Development

Publication Date

2019

Volume

13

Inclusive Pages

167-179

Document Type

Open Access Publication

DOI

10.1016/j.omtm.2019.01.007

Rights and Permissions

Suzuki-Hatano, S., Saha, M., Soustek, M. S., Kang, P. B., Byrne, B. J., Cade, W. T., & Pacak, C. A. (2019). AAV9-TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome. Molecular Therapy-Methods & Clinical Development, 13, 167-179. doi:10.1016/j.omtm.2019.01.007 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Suzuki-Hatano, Silveli; Saha, Madhurima; Soustek, Meghan S.; Kang, Peter B.; Byrne, Barry J.; Cade, W. Todd; and Pacak, Christina A., "AAV9-TAZ gene replacement ameliorates cardiac TMT proteomic profiles in a mouse model of Barth syndrome." Molecular Therapy-Methods & Clinical Development. 13, 167-179. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7968